Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers

Status: Active_not_recruiting
Location: See all (8) locations...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY

The purpose of this study is to learn more about the way physicians communicate with brain tumor patients. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. Ultimately, the investigators hope to use these findings to improve communication between patients, caregivers and their doctors.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ Patient Inclusion Criteria:

• 18 years or older

• Pathologic diagnosis of WHO grade IV glioma, as per MSKCC medical record or outside medical record.

• In the judgment of the consenting professional, proficiency in English that will allow the participant to be able to complete study questionnaires and assessments. Many of the study assessments are available only in English.

• At the time of consent, orientation to self, place, month and year

⁃ Caregiver Inclusion Criteria:

• 18 years or older

• Identified by the patient as a relative, friend, or partner with whom he or she has a significant relationship and who provides him or her informal (unpaid) care (i.e., physical or emotional assistance).

• In the judgment of the consenting professional, proficiency in English that will allow to complete study questionnaires and assessments. Many of the study assessments are available only in English.

⁃ Oncologist Inclusion Criteria:

• Treating Neuro-Oncologist in the Department of Neurology

Locations
United States
Michigan
Henry Ford Hospital
Detroit
New Jersey
Memorial Sloan Kettering Basking Ridge
Basking Ridge
Memorial Sloan Kettering Monmouth
Middletown
Memorial Sloan Kettering Bergen
Montvale
New York
Memorial Sloan Kettering Commack
Commack
Memorial Sloan Kettering Westchester
Harrison
Memorial Sloan Kettering Cancer Center
New York
Vermont
University of Vermont Medical Center
Burlington
Time Frame
Start Date: 2015-02
Completion Date: 2026-02
Participants
Target number of participants: 309
Treatments
Physicians, Patients, and Caregivers
This is a longitudinal study of patients with GBM with recurrent or multi-recurrent disease as determined by their neuro-oncologist (on the basis of clinical and/or radiological findings). Patients will indicate a single caregiver who will consent separately and perform separate assessments. The study assessments will evaluate the content of the discussion in which this change in disease status was communicated, as well as include patient-reported and caregiver-reported outcomes. We intend to accrue 160 total participants (80 patients and 80 caregivers) with complete post-discussion visit follow-ups over 18-24 months.
Sponsors
Collaborators: Weill Medical College of Cornell University
Leads: Memorial Sloan Kettering Cancer Center

This content was sourced from clinicaltrials.gov